CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
ChangChun High New Technology Industries Company Snapshot
ChangChun High New Technology Industries operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares ChangChun High New Technology Industries with three other companies in this sector in China: Shenzhen Hepalink Pharmaceutical Group Co Ltd (2018 sales of 4.81 billion Chinese Renmimbi [US$688.00 million] of which 100% was Pharmaceutical Manufacturing), Changjiang Runfa Medicine Co Ltd (4.67 billion Chinese Renmimbi [US$667.88 million] of which 72% was Medicine), and Shandong Xinhua Pharmaceutical Company Limited (5.21 billion Chinese Renmimbi [US$744.20 million] of which 49% was Preparations).

Sales Analysis. During the year ended December of 2018, sales at ChangChun High New Technology Industries were 5.32 billion Chinese Renmimbi (US$760.60 million). This is an increase of 31.8% versus 2017, when the company's sales were 4.04 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at ChangChun High New Technology Industries (and since 2013, sales have increased a total of 162%). Sales of Medication saw an increase of 38.2% in 2018, from 3.44 billion Chinese Renmimbi to 4.75 billion Chinese Renmimbi. Not all segments of ChangChun High New Technology Industries experienced an increase in sales in 2018: sales of Service Industry fell 37.3% to 25.42 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales). ChangChun High New Technology Industries also experienced decreases in sales in Real Estates (down 5.1% to 606.83 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
ChangChun High New Technology Industries
  Stock Performance Chart for ChangChun High New Technology Industries
 
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 476.42
(Figures in Chinese Renmimbi)
1 Week 0.1%   13 Weeks 18.8%  
4 Weeks 38.4%   52 Weeks 162.3%  
 
ChangChun High New Technology Industries Key Data:
  Ticker: 000661 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2018 Sales 5,322,624,456
(Year Ending Jan 2019).
Employees: 5,072
  Currency: Chinese Renmimbi Market Cap: 81,044,885,291
  Fiscal Yr Ends: December Shares Outstanding: 170,112,265
  Share Type: A Gu Closely Held Shares: 42,433,477
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.